J 2020

Copper Concentrations in Breast Cancer: A Systematic Review and Meta-Analysis

JOUYBARI, L., F. KIANI, F. ISLAMI, A. SANAGOO, F. SAYEHMIRI et. al.

Basic information

Original name

Copper Concentrations in Breast Cancer: A Systematic Review and Meta-Analysis

Authors

JOUYBARI, L., F. KIANI, F. ISLAMI, A. SANAGOO (guarantor), F. SAYEHMIRI, B. HOSNEDLOVA, M. D. DOSA, René KIZEK (203 Czech Republic, belonging to the institution), S. CHIRUMBOLO and G. BJORKLUND

Edition

Current Medicinal Chemistry, Sharjah, Betham Science Publishers, 2020, 0929-8673

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

United Arab Emirates

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.530

RIV identification code

RIV/00216224:14160/20:00118452

Organization unit

Faculty of Pharmacy

UT WoS

000589111000005

Keywords in English

Copper; breast cancer; women; blood; breast tissue; hair analysis

Tags

Tags

International impact, Reviewed
Změněno: 25/3/2021 18:00, Mgr. Hana Hurtová

Abstract

V originále

Breast cancer is the most common neoplasm, comprising 16% of all women's cancers worldwide. Research of Copper (Cu) concentrations in various body specimens have suggested an association between Cu levels and breast cancer risks. This systematic review and meta-analysis summarize the results of published studies and examine this association. We searched the databases PubMed, Scopus, Web of Science, and Google Scholar and the reference lists of relevant publications. The Standardized Mean Differences (SMDs) between Cu levels in cancer cases and controls and corresponding Confidence Intervals (CIs), as well as I-2 statistics, were calculated to examine heterogeneity. Following the specimens used in the original studies, the Cu concentrations were examined in three subgroups: serum or plasma, breast tissue, and scalp hair. We identified 1711 relevant studies published from 1984 to 2017. There was no statistically significant difference between breast cancer cases and controls for Cu levels assayed in any studied specimen; the SMD (95% CI) was -0.01 (-1.06 - 1.03; P = 0.98) for blood or serum, 0.51 (-0.70 - 1.73; P = 0.41) for breast tissue, and -0.88 (-3.42 - 1.65; P = 0.50) for hair samples. However, the heterogeneity between studies was very high (P < 0.001) in all subgroups. We did not find evidence for publication bias (P = 0.91). The results of this meta-analysis do not support an association between Cu levels and breast cancer. However, due to high heterogeneity in the results of original studies, this conclusion needs to be confirmed by well-designed prospective studies.